Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-1 of 1
Keywords: FACBC
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
PSA and PSA Kinetics as Predictors for 18F-Fluciclovine PET/CT Positivity in Biochemically Recurrent Prostate Cancer
Available to PurchaseSubject Area:
Further Areas
Fabio Crocerossa, Umberto Carbonara, Jayashree Parekh, Alfredo Urdaneta, Samuel Weprin, Rocco Damiano, Mayer B. Grob, Lance J. Hampton, Asit Paul, Riccardo Autorino, Francesco Cantiello
Journal:
Urologia Internationalis
Urol Int (2022) 106 (9): 920–927.
Published Online: 21 December 2021
...: (a) those already undergoing salvage treatments at the time of PET/CT, (b) those with newly diagnosed PCa, and (c) those with initial diagnosis of metastatic PCa (M1). 18 F-Fluciclovine (FACBC, Axumin®) PET/CT is one of the imaging techniques currently employed to restage PCa. Despite the recent...
